SOX2 and non-small cell lung carcinoma: Collectively, these findings highlight the key role of SOX2 in the development and progression of NSCLC, particularly squamous cell carcinoma, and support its potential as a promising candidate for diagnostic and therapeutic targeting in clinical settings.